U.S. STOCKS ON THE MOVE-Domino's Pizza, Eli Lilly, Revvity
Brief: Biohaven Announces Investment Up To $600 Mln By Oberland Capital
Biohaven jumps after securing up to $600 million investment from Oberland Capital
Brief: Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board
U.S. STOCKS ON THE MOVE-Mobileye, Visionary Holdings, Wolfspeed
Biohaven drops as Morgan Stanley cuts PT after bipolar drug failure
U.S. STOCKS ON THE MOVE-THOR Industries, TG Therapeutics, Target
U.S. STOCKS ON THE MOVE-Melco Resorts, Chipotle, Allegro
Biohaven slides on wider-than-expected quarterly loss
Focus: Next generation weight loss drugs aim to save muscle
Factbox: Fat, not muscle: drugmakers in race for next weight-loss breakthrough
U.S. STOCKS ON THE MOVE-Marriott International, Coty, Carlyle Group
U.S. STOCKS ON THE MOVE-Biohaven, Ecolab, Firefly
Biohaven rises as FDA grants priority review status for brain disorder drug
Brief: Biohaven Announces FDA Acceptance And Priority Review Of Troriluzole New Drug Application
Develop Three Novel Bispecific ADC Programs
U.S. STOCKS ON THE MOVE-Teradyne, Keysight Technologies, Ametek
U.S. STOCKS ON THE MOVE-HeartBeam, Teradyne, Keysight Technologies
U.S. STOCKS ON THE MOVE-Novo Nordisk, Tesla, MicroStrategy